  Neural inflammation immediately follows the onset of ischemic stroke. During
this process, microglial cells can be activated into two different phenotypes:
the M1 phenotype, which can worsen brain injury by producing pro-inflammatory
cytokines; or the M2 phenotype, which can aid in long term recovery by
producing anti-inflammatory cytokines. In this study, we formulate a nonlinear
system of differential equations to model the activation of microglia
post-ischemic stroke, which includes bidirectional switching between the
microglia phenotypes, as well as the interactions between these cells and the
cytokines that they produce. Further, we explore neuroprotectant-based modeling
strategies to suppress the activation of the detrimental M1 phenotype, while
promoting activation of the beneficial M2 phenotype. Through use of global
sensitivity techniques, we analyze the effects of the model parameters on the
ratio of M1 to M2 microglia and the total number of activated microglial cells
in the system over time. Results demonstrate the significance of bidirectional
microglia phenotype switching on the ratio of M1 to M2 microglia, in both the
absence and presence of neuroprotectant terms. Simulations further suggest that
early inhibition of M1 activation and support of M2 activation leads to a
decreased minimum ratio of M1 to M2 microglia and allows for a larger number of
M2 than M1 cells for a longer time period.
